DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-9.26%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$321M
AUM Growth
-$44.2M
(-12%)
Cap. Flow
-$7.59M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
50.52%
Holding
83
New
10
Increased
22
Reduced
13
Closed
8
Top Buys
| 1 |
Cytokinetics
CYTK
|
$4.32M |
| 2 |
TSVT
2seventy bio
TSVT
|
$3.73M |
| 3 |
Axogen
AXGN
|
$3.02M |
| 4 |
Merus
MRUS
|
$2.36M |
| 5 |
Tandem Diabetes Care
TNDM
|
$2.3M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$24.1M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$8.48M |
| 3 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$5.93M |
| 4 |
Lyra Therapeutics
LYRA
|
$1.48M |
| 5 |
Revolution Medicines
RVMD
|
$1.08M |
Sector Composition
| 1 | Healthcare | 82.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Lyra Therapeutics
LYRA
$11.8M
| – | – |
-7,222
| Closed | -$1.48M |
|
|
SAGE
77
DELISTED
Sage Therapeutics
SAGE
| – | – |
-180,306
| Closed | -$8.48M |
|
|
MDNA
78
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
| – | – |
-660,000
| Closed | -$318K |
|
|
SURF
79
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| – | – |
-1,100,000
| Closed | -$957K |
|
|
PRDS
80
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| – | – |
-430,291
| Closed | -$779K |
|
|
DICE
81
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| – | – |
-127,585
| Closed | -$5.93M |
|
|
ISEE
82
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-612,975
| Closed | -$24.1M |
|